Drug Name |
Orphenadrine citrate |
Drug ID |
BADD_D01626 |
Description |
A muscarinic antagonist used to treat drug-induced parkinsonism and to relieve pain from muscle spasm. |
Indications and Usage |
Indicated for the treatment of Parkinson's disease. |
Marketing Status |
Prescription; Discontinued |
ATC Code |
M03BC01 |
DrugBank ID |
DB01173
|
KEGG ID |
D00774
|
MeSH ID |
D009966
|
PubChem ID |
83823
|
TTD Drug ID |
D0D9FV
|
NDC Product Code |
49452-4936; 51927-0006; 63275-9918; 22568-1022; 61919-177; 51552-1353; 63187-122; 43063-407; 63187-632; 61919-507; 0641-6182; 17478-538; 71335-0117; 80425-0117; 68788-9138; 67763-119; 50090-0169; 66267-158; 49999-046; 43386-480; 51927-0127; 50090-2438; 50090-3150; 46016-0140; 0591-3222; 63629-1564; 0115-2011; 67296-0709; 71554-012; 38779-0452; 53002-5430; 60760-810; 0185-0022 |
Synonyms |
Orphenadrine | Methyldiphenylhydramine | Lysantin | Mefenamine | Mephenamine | Norflex | Orphenadrine Citrate | Citrate, Orphenadrine | Orphenadrine Hydrochloride | Hydrochloride, Orphenadrine | Sodium Mefenamine | Mefenamine, Sodium | Disipal | Norflex Orphenadrine Citrate | Citrate, Norflex Orphenadrine | Orphenadrine Citrate, Norflex |